Pulmonx Corp
LUNGAs of the close on Sep 25, 2026
Price
$1.91
Market cap
$82M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$1.16
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Pulmonx Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 9, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Physician Wealth Advisors, Inc. | 2026-03-31 | 855 | $1.1K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 7 | $9 | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 61,000 | $78.7K | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 18,750 | $24.2K | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 71,319 | $92K | SEC filing |
| IEQ CAPITAL, LLC | 2026-03-31 | 21,587 | $27.8K | SEC filing |
| PRIMECAP MANAGEMENT CO/CA/ | 2026-03-31 | 4,724,991 | $6.1M | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 3,617 | $4.67K | SEC filing |
| PERKINS CAPITAL MANAGEMENT INC | 2026-03-31 | 41,000 | $52.9K | SEC filing |
| FEDERATED HERMES, INC. | 2026-03-31 | 1,629 | $2.1K | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 57,009 | $73.5K | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 141,920 | $183K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 258 | $333 | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 223,450 | $288K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 683,435 | $882K | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 82,492 | $106K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 158 | $204 | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 14,090 | $18.5K | SEC filing |
| Centiva Capital, LP | 2026-03-31 | 153,882 | $199K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 248 | $320 | SEC filing |
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- TWO SIGMA INVESTMENTS, LP: 132,770 shares reported 2025-12-31; 68,612 shares reported 2026-03-31.
- Optiver Holding B.V.: 3,622 shares reported 2025-12-31; 3,366 shares reported 2026-03-31.
- BRAIDWELL LP: 752,541 shares reported 2025-12-31; 752,541 shares reported 2026-03-31.
- NEW YORK STATE COMMON RETIREMENT FUND: 6,914 shares reported 2025-12-31; 6,914 shares reported 2026-03-31.
- Atlantic Union Bankshares Corp: 10 shares reported 2025-12-31; 10 shares reported 2026-03-31.
- PRICE T ROWE ASSOCIATES INC /MD/: 19,884 shares reported 2025-12-31; 19,884 shares reported 2026-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 292,000 shares reported 2025-12-31; 320,300 shares reported 2026-03-31.
- MERCER GLOBAL ADVISORS INC /ADV: 41,265 shares reported 2025-12-31; 48,767 shares reported 2026-03-31.
- NINE MASTS CAPITAL Ltd: 10,106 shares reported 2025-12-31; 38,598 shares reported 2026-03-31.
- Bank of New York Mellon Corp: 92,787 shares reported 2025-12-31; 92,720 shares reported 2026-03-31.
- NANO CAP NEW MILLENNIUM GROWTH FUND L P: 85,000 shares reported 2025-12-31; 157,500 shares reported 2026-03-31.
98 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Pulmonx Corp's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-02 · French Glendon E. III: Larger than 170 of the 183 other insider sales of Common Stock on file. SEC filing
- 2026-06-01 · French Glendon E. III: Larger than 181 of the 183 other insider sales of Common Stock on file. SEC filing
- 2026-03-02 · French Glendon E. III: Larger than all 183 other insider sales of Common Stock on file. SEC filing
- 2025-12-08 · Florin Daniel P: Larger than 179 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-06-12 · Ferrari Richard: Larger than 165 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-03-20 · French Glendon E. III: Larger than 174 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-03-03 · Joshi Mehul: Larger than 172 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-03-03 · Williamson Steven S.: Larger than 180 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-03-03 · Lehman David Aaron: Larger than 171 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-02-20 · French Glendon E. III: Larger than 182 of the 183 other insider sales of Common Stock on file. SEC filing
- 2025-02-20 · French Glendon E. III: Larger than 169 of the 183 other insider sales of Common Stock on file. SEC filing
- 2024-11-22 · French Glendon E. III: Larger than 174 of the 183 other insider sales of Common Stock on file. SEC filing
- 2024-10-17 · French Glendon E. III: Larger than 174 of the 183 other insider sales of Common Stock on file. SEC filing
- 2024-09-12 · French Glendon E. III: Larger than 174 of the 183 other insider sales of Common Stock on file. SEC filing
- 2024-02-15 · French Glendon E. III: Larger than 174 of the 183 other insider sales of Common Stock on file. SEC filing
- 2024-01-18 · French Glendon E. III: Larger than 166 of the 183 other insider sales of Common Stock on file. SEC filing
- 2023-12-21 · French Glendon E. III: Larger than 166 of the 183 other insider sales of Common Stock on file. SEC filing
- 2023-07-20 · French Glendon E. III: Larger than 173 of the 183 other insider sales of Common Stock on file. SEC filing
- 2023-06-15 · French Glendon E. III: Larger than 166 of the 183 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-02 | French Glendon E. III · President and CEO | Common Stock | S — Open market or private sale | −13,511 | 1.57 | SEC filing |
| 2026-06-01 | Lehman David Aaron · GENERAL COUNSEL | Common Stock | S — Open market or private sale | −3,876 | 1.54 | SEC filing |
| 2026-06-01 | Lehman David Aaron · GENERAL COUNSEL | Common Stock | S — Open market or private sale | −4,915 | 1.54 | SEC filing |
| 2026-06-01 | Rose Geoffrey Beran · CHIEF COMMERCIAL OFFICER | Common Stock | S — Open market or private sale | −1,778 | 1.54 | SEC filing |
| 2026-06-01 | French Glendon E. III · President and CEO | Common Stock | S — Open market or private sale | −4,171 | 1.54 | SEC filing |
| 2026-06-01 | French Glendon E. III · President and CEO | Common Stock | S — Open market or private sale | −38,467 | 1.54 | SEC filing |
| 2026-06-01 | Radhakrishnan Srikanth · Chief Science &Techn. Officer | Common Stock | S — Open market or private sale | −5,969 | 1.54 | SEC filing |
| 2026-06-01 | Radhakrishnan Srikanth · Chief Science &Techn. Officer | Common Stock | S — Open market or private sale | −2,153 | 1.54 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | Burns Thomas William · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-05 | Florin Daniel P · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-05 | Mead Dana G Jr. · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-05 | Ferrari Richard · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-05 | Sullivan Tiffany · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-06-05 | Melenikiotou Georgia · Director | Common Stock | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-03-02 | Rose Geoffrey Beran · CHIEF COMMERCIAL OFFICER | Common Stock | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-03-02 | Lehman David Aaron · GENERAL COUNSEL | Common Stock | A — Grant, award, or other acquisition | +150,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.